Resilience Enhancement Online Training for Nurses (REsOluTioN) Trial

Sponsor
Oxford Brookes University (Other)
Overall Status
Completed
CT.gov ID
NCT05074563
Collaborator
(none)
100
1
2
6.6
15.1

Study Details

Study Description

Brief Summary

The purpose of the study is to pilot a new training which aims to foster resilience to some of the clinical and workload pressures that nurses encounter on a daily basis.

Condition or Disease Intervention/Treatment Phase
  • Other: REsOluTioN (Resilience Enhancement Online Training for Nurses)
  • Other: Control
N/A

Detailed Description

Background:

Many nurses are exposed to challenges in their clinical setting on a daily basis, which often results in them experiencing stress, burnout and decreased satisfaction with their work; this can have a long term impact on the recruitment and retention rate of these nurses. This stress has intensified over the last year due to the COVID-19 pandemic. The online training being piloted in this trial has been adapted from a recent face-to-face resilience enhancement programme developed for nurses in the UK. By creating an online training, it is hoped that this intervention will be accessible to more nurses, particularly in the context of the COVID-19 pandemic.

Objectives:

The purpose of this trial is to understand whether the online training can improve levels of resilience, psychological, and wellbeing, and whether or not it has changed the way nurses experience in their work environment.

Methods:

All registered nurses working at Oxford Health NHS Foundation Trust during the COVID-19 pandemic will be invited. We intend to recruit 100 nurses who are currently working at Oxford Health NHS Foundation Trust to participate in the pilot study. Recruited nurses will be randomised to the intervention group or the control group. Nurses who are randomised to the intervention group will be invited to do the online training over a four week period. There will be the opportunity to participate in four 2 hour online facilitated sessions during the four-week training period. Nurses will also be asked to complete 30 minutes of independent pre-work ahead of each of the facilitated sessions. The sessions will cover a range of topics and will tackle areas such as building hardiness and maintaining a positive outlook; emotional intelligence and intellectual flexibility; reflective and critical thinking; enabling spirituality and achieving work-life balance. The training also involves twice weekly mentorship sessions ranging between 30 and 60 minutes.

Nurses will be invited to complete two surveys (pre- and post- intervention) which will be used to evaluate the trial outcomes and feedback on training. On completion of the post-intervention survey, nurses will receive a certificate for 10 hours of CPD. Nurses randomised to the control group will only be invited to take part in the pre- and post- intervention surveys, but will not use the online training. However, after completing the survey, nurses will be given the opportunity to complete the pre-work and access the online facilitated sessions so they can receive their CPD certificate.

Implications:

Once the training has been piloted, the effectiveness of the online training will be evaluated at national level.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Masking Description:
Participants will not be blinded to group allocation and will complete self-reported surveys online. One of the study investigators not involved in the delivery of training or randomisation process and who will analyse the survey responses will be blinded to treatment assignment.
Primary Purpose:
Other
Official Title:
Enhancing Resilience in the Nursing Workforce in the COVID-19 Environment: Transitioning From Face-to-face to Online Learning
Actual Study Start Date :
Oct 1, 2021
Actual Primary Completion Date :
Feb 14, 2022
Actual Study Completion Date :
Apr 20, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Online REsOluTioN training

The active comparator arm will receive access to online REsOluTioN training to enhance resilience.

Other: REsOluTioN (Resilience Enhancement Online Training for Nurses)
The online REsOluTioN training involves virtual or face-to-face mentorship sessions and facilitated online interactive group sessions on four topics (Building hardiness and maintaining a positive outlook, Intellectual flexibility and Emotional Intelligence; Achieving life balance and enabling spirituality and Reflective and critical thinking). The training will be of four-week duration. Over the four-week period, the training will comprise 4x120 minute facilitated online group sessions; 4x30 minute independent learning activities; and eight 3:1 online mentoring sessions delivered between 30 and 60 minutes at flexible timings.

Other: Control

The control arm will have no access to the online training.

Other: Control
Nurses randomised to the control group will only be invited to take part in the pre- and post- intervention surveys, but will not use the online training. However, after completing the survey, nurses will be given the opportunity to complete the pre-work and access the facilitated sessions of the training so that they can receive their CPD certificate.

Outcome Measures

Primary Outcome Measures

  1. Resilience [Four weeks]

    Brief Resilience Scale - Scores range from 1 (low resilience) to 5 (high resilience).

Secondary Outcome Measures

  1. Mental wellbeing [Four weeks]

    Warwick-Edinburgh Mental Wellbeing Scale -The total score of the 14-item Warwick-Edinburgh Mental Wellbeing Scale ranges from 14-70. Higher scores indicate higher level of mental well-being.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Any registered, non-agency nurses working at Oxford Health NHS Foundation Trust

  • Willing to participate and provide signed consent

Exclusion Criteria:
  • Not willing to participate and provide signed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Health and Life Sciences, Oxford Brookes University Oxford Oxfordshire United Kingdom

Sponsors and Collaborators

  • Oxford Brookes University

Investigators

  • Principal Investigator: Cathy Henshall, PhD, Oxford Brookes University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Dr Cathy Henshall, Reader, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford Brookes University
ClinicalTrials.gov Identifier:
NCT05074563
Other Study ID Numbers:
  • 21/HRA/1418
First Posted:
Oct 12, 2021
Last Update Posted:
May 26, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr Cathy Henshall, Reader, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford Brookes University

Study Results

No Results Posted as of May 26, 2022